Skip to main content
An official website of the United States government
Email

London Global Cancer Week: Utilizing Cancer Research Funding to Inform Action and Drive Collaboration

November 16, 2022 | 11:00 AM – 1:00 PM

Add to Outlook Calendar

Register Now

Session Description

The National Cancer Institute Center for Global Health (CGH) will host a session in collaboration with London Global Cancer Week (LGCW) 2022. This session will give an overview of three efforts to map and track global cancer research and research funding, led by the International Cancer Research Partnership (ICRP), WorldView (formerly World Report) hosted by the National Institutes of Health, and the NCI's Center for Global Health through the Global Oncology Survey of NCI-Designated Cancer Centers. Following an overview of each of these mapping efforts, there will be a case example of how data from these resources have been utilized to inform action and drive collaboration. The last portion of the session will be dedicated to a hands-on walkthrough of the resources, and an opportunity for participants to ask the experts about how to utilize these tools to develop research questions, seek training opportunities, identify funding sources, find potential collaborating partners, and more.

Agenda

 

1. Introductory Remarks: Why is it Important to Map and Track Research and Research Funding Data

Kalina Duncan, Dr.P.H., M.P.H.
Chief, Partnerships and Dissemination Branch
Center for Global Health, National Cancer Institute
Headshot of Dr. Kalina Duncan
2. International Cancer Research Partnership: A Public Database and Partnership to Enhance Global 
Collaboration and Strategic Coordination of Cancer Research

Lynne Davies, Ph.D.
Operations Manager, International Cancer Research Partnership
Headshot photo of Dr. Lynne Davies
Panagiota Mitrou, Ph.D.
Director, Research and Innovation
World Cancer Research Fund 

3. WorldView: an Atlas of Health Research Funding Hosted by the National Institutes of Health    

Michael Cheetham, B.A.
Senior Science Policy Analyst 
Office of Portfolio Analysis
Division of Program Coordination, Planning, & Strategic Initiatives
Office of the Director, National Institutes of Health
Anna Laura Ross, Ph.D.
Unit Head, Emerging Technologies, Research Prioritization, and Support
Science Division, World Health Organization
Headshot photo of Dr. Anna Laura Ross

4. NCI Global Oncology Survey of NCI-Designated Cancer Centers

Elise Garton, M.Sc.
Health Specialist
Center for Global Health, National Cancer Institute
headshot photo of Ms. Elise Garton
S. Nabeel Zafar, M.D., M.P.H.
Assistant Professor, Division of Surgical Oncology
University of Wisconsin School of Medicine and Public Health
Lead, Global Oncology Program
University of Wisconsin Carbone Cancer Center 

5. Interactive Q&A and Discussion

6. Breakout Sessions:  Expert-led Interactive Database Exploration/”Office Hours"

Participants will be able to join experts in separate virtual breakout rooms to learn more about the International Cancer Research Partnership (ICRP) and its database, with Dr. Lynne Davies and Dr. Panagiota Mitrou; WorldView and the WHO Global Health Observatory, with Michael Cheetham and Dr. Anna Laura Ross; and, the Global Oncology Survey of NCI-Designated Cancer Centers, with Elise Garton and Dr. Nabeel Zafar. 
 
This will allow participants to ask the experts questions directly about how to navigate the ICRP, WorldView, and WHO Global Health Observatory databases through an interactive walkthrough guided by participant interest and questions (e.g., how to use these resources to conduct a portfolio analysis, establish a research question, seek collaborations and training opportunities, etc.). 
 
In addition, Elise Garton will be available to share and discuss additional results of the Global Oncology Survey of NCI-Designated Cancer Centers, answer questions related to the methods and findings relevant to global cancer research funding and collaboration, and how this model could be replicated in other settings, as these types of survey can provide valuable data to understand the current state, priorities, and trends of global oncology. 

 

Email